Technology fronts.

Front

AI in dementia care

Software can help read scans or organise notes. It is not a clinician and it is not a diagnosis.

Front

Anti-amyloid treatment

Antibodies that lower amyloid plaques in early symptomatic Alzheimer’s disease, with ARIA monitoring.

Front

Anti-tau research

Tau is the tangle protein. Treatments that lower or block tau remain investigational.

Front

Care delivery

Who coordinates care, how families get respite, and how clinics monitor antibodies are delivery problems, not only science problems.

Front

Digital cognition

Apps and remote tests can track change. They do not diagnose dementia on their own.

Front

Fluid biomarkers

Spinal-fluid and blood tests that can support an Alzheimer’s biology question.

Front

Genetics

Genes can change risk and, rarely, cause familial disease. ApoE ε4 also changes antibody-safety counselling.

Front

Imaging

Scans that show brain structure and, in selected people, amyloid or other biology.

Front

Lifestyle and risk

Hearing, blood pressure, smoking, sleep, and movement are part of brain-health care. They are not a substitute for diagnosis.

Front

Neuroinflammation

Immune activity in the brain is a research front, not a licensed dementia cure.

Front

Symptomatic care

Medicines and non-drug support aimed at symptoms, not at reversing the disease.